These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 36973454

  • 1. Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome.
    Körber V, Stainczyk SA, Kurilov R, Henrich KO, Hero B, Brors B, Westermann F, Höfer T.
    Nat Genet; 2023 Apr; 55(4):619-630. PubMed ID: 36973454
    [Abstract] [Full Text] [Related]

  • 2. Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance.
    Fransson S, Martinez-Monleon A, Johansson M, Sjöberg RM, Björklund C, Ljungman G, Ek T, Kogner P, Martinsson T.
    Sci Rep; 2020 Dec 31; 10(1):22432. PubMed ID: 33384420
    [Abstract] [Full Text] [Related]

  • 3. A mechanistic classification of clinical phenotypes in neuroblastoma.
    Ackermann S, Cartolano M, Hero B, Welte A, Kahlert Y, Roderwieser A, Bartenhagen C, Walter E, Gecht J, Kerschke L, Volland R, Menon R, Heuckmann JM, Gartlgruber M, Hartlieb S, Henrich KO, Okonechnikov K, Altmüller J, Nürnberg P, Lefever S, de Wilde B, Sand F, Ikram F, Rosswog C, Fischer J, Theissen J, Hertwig F, Singhi AD, Simon T, Vogel W, Perner S, Krug B, Schmidt M, Rahmann S, Achter V, Lang U, Vokuhl C, Ortmann M, Büttner R, Eggert A, Speleman F, O'Sullivan RJ, Thomas RK, Berthold F, Vandesompele J, Schramm A, Westermann F, Schulte JH, Peifer M, Fischer M.
    Science; 2018 Dec 07; 362(6419):1165-1170. PubMed ID: 30523111
    [Abstract] [Full Text] [Related]

  • 4. Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
    Peifer M, Hertwig F, Roels F, Dreidax D, Gartlgruber M, Menon R, Krämer A, Roncaioli JL, Sand F, Heuckmann JM, Ikram F, Schmidt R, Ackermann S, Engesser A, Kahlert Y, Vogel W, Altmüller J, Nürnberg P, Thierry-Mieg J, Thierry-Mieg D, Mariappan A, Heynck S, Mariotti E, Henrich KO, Gloeckner C, Bosco G, Leuschner I, Schweiger MR, Savelyeva L, Watkins SC, Shao C, Bell E, Höfer T, Achter V, Lang U, Theissen J, Volland R, Saadati M, Eggert A, de Wilde B, Berthold F, Peng Z, Zhao C, Shi L, Ortmann M, Büttner R, Perner S, Hero B, Schramm A, Schulte JH, Herrmann C, O'Sullivan RJ, Westermann F, Thomas RK, Fischer M.
    Nature; 2015 Oct 29; 526(7575):700-4. PubMed ID: 26466568
    [Abstract] [Full Text] [Related]

  • 5. Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation.
    Cetinkaya C, Martinsson T, Sandgren J, Träger C, Kogner P, Dumanski J, Díaz de Ståhl T, Hedborg F.
    BMC Cancer; 2013 May 09; 13():231. PubMed ID: 23656755
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of genes identified by microarray analysis in favorable neuroblastoma.
    Kamei N, Hiyama K, Yamaoka H, Kamimatsuse A, Onitake Y, Sueda T, Hiyama E.
    Pediatr Surg Int; 2009 Nov 09; 25(11):931-7. PubMed ID: 19701758
    [Abstract] [Full Text] [Related]

  • 7. Association of age at diagnosis and genetic mutations in patients with neuroblastoma.
    Cheung NK, Zhang J, Lu C, Parker M, Bahrami A, Tickoo SK, Heguy A, Pappo AS, Federico S, Dalton J, Cheung IY, Ding L, Fulton R, Wang J, Chen X, Becksfort J, Wu J, Billups CA, Ellison D, Mardis ER, Wilson RK, Downing JR, Dyer MA, St Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project.
    JAMA; 2012 Mar 14; 307(10):1062-71. PubMed ID: 22416102
    [Abstract] [Full Text] [Related]

  • 8. Neuroblastoma. Effect of genetic factors on prognosis and treatment.
    Brodeur GM, Azar C, Brother M, Hiemstra J, Kaufman B, Marshall H, Moley J, Nakagawara A, Saylors R, Scavarda N.
    Cancer; 1992 Sep 15; 70(6 Suppl):1685-94. PubMed ID: 1325279
    [Abstract] [Full Text] [Related]

  • 9. High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta, is associated with favorable prognosis in human neuroblastomas.
    Kawamoto T, Ohira M, Hamano S, Hori T, Nakagawara A.
    Int J Oncol; 2003 Apr 15; 22(4):815-22. PubMed ID: 12632073
    [Abstract] [Full Text] [Related]

  • 10. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T, Sjöberg RM, Hedborg F, Kogner P.
    Cancer Res; 1995 Dec 01; 55(23):5681-6. PubMed ID: 7585654
    [Abstract] [Full Text] [Related]

  • 11. Spontaneous regression of neuroblastoma.
    Brodeur GM.
    Cell Tissue Res; 2018 May 01; 372(2):277-286. PubMed ID: 29305654
    [Abstract] [Full Text] [Related]

  • 12. Growth, progression and chromosome instability of Neuroblastoma: a new scenario of tumorigenesis?
    Tonini GP.
    BMC Cancer; 2017 Jan 05; 17(1):20. PubMed ID: 28056863
    [Abstract] [Full Text] [Related]

  • 13. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.
    Vandesompele J, Baudis M, De Preter K, Van Roy N, Ambros P, Bown N, Brinkschmidt C, Christiansen H, Combaret V, Lastowska M, Nicholson J, O'Meara A, Plantaz D, Stallings R, Brichard B, Van den Broecke C, De Bie S, De Paepe A, Laureys G, Speleman F.
    J Clin Oncol; 2005 Apr 01; 23(10):2280-99. PubMed ID: 15800319
    [Abstract] [Full Text] [Related]

  • 14. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
    Matsunaga T, Shirasawa H, Tanabe M, Ohnuma N, Kawamura K, Etoh T, Takahashi H, Simizu B.
    Int J Cancer; 1994 Sep 15; 58(6):793-8. PubMed ID: 7523310
    [Abstract] [Full Text] [Related]

  • 15. Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.
    Tomioka N, Oba S, Ohira M, Misra A, Fridlyand J, Ishii S, Nakamura Y, Isogai E, Hirata T, Yoshida Y, Todo S, Kaneko Y, Albertson DG, Pinkel D, Feuerstein BG, Nakagawara A.
    Oncogene; 2008 Jan 17; 27(4):441-9. PubMed ID: 17637744
    [Abstract] [Full Text] [Related]

  • 16. TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.
    Valentijn LJ, Koster J, Zwijnenburg DA, Hasselt NE, van Sluis P, Volckmann R, van Noesel MM, George RE, Tytgat GA, Molenaar JJ, Versteeg R.
    Nat Genet; 2015 Dec 17; 47(12):1411-4. PubMed ID: 26523776
    [Abstract] [Full Text] [Related]

  • 17. Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
    Padovan-Merhar OM, Raman P, Ostrovnaya I, Kalletla K, Rubnitz KR, Sanford EM, Ali SM, Miller VA, Mossé YP, Granger MP, Weiss B, Maris JM, Modak S.
    PLoS Genet; 2016 Dec 17; 12(12):e1006501. PubMed ID: 27997549
    [Abstract] [Full Text] [Related]

  • 18. Biological categories of neuroblastoma based on the international neuroblastoma pathology classification for treatment stratification.
    Nakazawa A.
    Pathol Int; 2021 Apr 17; 71(4):232-244. PubMed ID: 33657257
    [Abstract] [Full Text] [Related]

  • 19. Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.
    Spitz R, Betts DR, Simon T, Boensch M, Oestreich J, Niggli FK, Ernestus K, Berthold F, Hero B.
    Cancer Genet Cytogenet; 2006 May 17; 167(1):51-6. PubMed ID: 16682287
    [Abstract] [Full Text] [Related]

  • 20. Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment.
    Roth SA, Knutsen E, Fiskaa T, Utnes P, Bhavsar S, Hald ØH, Løkke C, Mestdagh P, Johansen SD, Flægstad T, Einvik C.
    Cancer Lett; 2016 Mar 01; 372(1):128-36. PubMed ID: 26708804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.